Tesamorelin

Is a synthetic GHRH analog approved by the FDA under the brand name Egrifta for the reduction of visceral fat. It stimulates the pituitary gland to release growth hormone in a natural pulsatile pattern, improving body composition, reducing abdominal fat, and supporting sleep quality. Clinically dosed at 1 mg nightly for consistent results. The GH-stimulating peptide with the strongest medical validation available.